Company Filing History:
Years Active: 2013
Title: Ulleras Erik: Innovator in Immunotoxicity Research
Introduction
Ulleras Erik is a notable inventor based in Uppsala, Sweden. He has made significant contributions to the field of immunotoxicity through his innovative research and patented methods. His work focuses on characterizing the immunotoxic activity of xenobiotic substances, which is crucial for understanding their potential health impacts.
Latest Patents
Ulleras Erik holds a patent titled "Tools and methods useful in characterising the immunotoxic activity of xenobiotic substances." This patent describes a method for the characterization of tested substances, particularly useful in the study of their toxicity, especially immunotoxicity. The patent also outlines cell lines and nucleic acids that can be utilized in this method, particularly for obtaining cell-chip collections intended for immunotoxicity assays. He has 1 patent to his name.
Career Highlights
Throughout his career, Ulleras Erik has worked with several esteemed organizations. He has been associated with the National Institute of Public Health and the Environment, the Laboratory for Pathology and Immunobiology, and the Norwegian Institute of Public Health, specifically in the Division of Environmental Medicine. His work in these institutions has contributed to advancements in public health and environmental medicine.
Collaborations
Ulleras Erik has collaborated with notable colleagues, including Tove Ringerike and Robert Jan Vandehriel. These collaborations have further enriched his research and expanded the impact of his work in the field of immunotoxicity.
Conclusion
Ulleras Erik's contributions to immunotoxicity research through his patented methods and collaborations with esteemed institutions and colleagues highlight his role as an innovator in this critical area of study. His work continues to influence the understanding of the health impacts of xenobiotic substances.